CN114404550A - A Chinese medicinal composition for treating diabetes and its complications - Google Patents
A Chinese medicinal composition for treating diabetes and its complications Download PDFInfo
- Publication number
- CN114404550A CN114404550A CN202210125300.7A CN202210125300A CN114404550A CN 114404550 A CN114404550 A CN 114404550A CN 202210125300 A CN202210125300 A CN 202210125300A CN 114404550 A CN114404550 A CN 114404550A
- Authority
- CN
- China
- Prior art keywords
- complications
- parts
- diabetes
- traditional chinese
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating diabetes and complications thereof, which comprises the following raw materials: 100-200 parts of emblic leafflower fruit, 80-120 parts of turmeric and 80-120 parts of barberry bark. The invention can comprehensively regulate the functions of organs such as stomach, liver, kidney, bladder and the like, and fundamentally treat diabetes. The traditional Chinese medicine composition can effectively treat diabetes and complications thereof, has the effect of diuresis, and has obvious curative effects on complications such as renal hypofunction, edema of lower limbs, diabetic foot and the like caused by diabetes.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating diabetes and complications thereof.
Background
Diabetes Mellitus (DM) is a disorder of sugar, fat, protein, water and salt metabolism, manifested by hyperglycemia, Diabetes, and the like, due to defective insulin secretion in vivo and low insulin response (insulin resistance). DM is largely classified into type 1 diabetes (IDDM), and type 2 diabetes (NIDDM), which is a Non-Insulin-dependent diabetes mellitus. Type 1 diabetes is an absolute deficiency of insulin, often due to an absolute deficiency of insulin caused by destruction of the islet beta cells, which must rely primarily on insulin therapy. Type 2 diabetes is primarily caused by insulin resistance and a relative lack of insulin secretion. Type 2 diabetes accounts for the majority of diabetes, and can account for more than 90%. The drug therapy for type 2 diabetes mainly utilizes drugs to control the rise of blood sugar and prevent and treat complications, and the currently clinically applied hypoglycemic chemical drugs mainly comprise sulfonylureas, biguanides, alpha glycosidase inhibitors, thiazolidinediones, non-sulfonylurea insulin secretagogues and the like.
According to the theory of traditional medicine, diabetes belongs to the category of diabetes in traditional Chinese medicine and the category of the disease of Beijing Nissaku in Tibetan medicine. The Jingni Tibetan language has the meaning of frequent urination, which is characterized in that the urine volume is reduced and the urine becomes turbid and dripping is continuous due to excessive bacon and fat caused by overeating salty and sweet diet and cold and heavy foods and failing to rise to essence such as blood, muscle, bone, marrow and the like because of the lack of movement, sitting or lying in the wet land: "because (urine) is mixed with essence in vivo, the disease is very difficult to treat". The Tibetan medicine considers that the treatment of the disease is very difficult, but the general treatment principle is that four Tibetan medicine therapies of diet, daily life, medicine, external treatment and the like are combined to reduce the bacon and fat, regulate the functions of organs such as stomach, liver, kidney, bladder and the like, make essence and dregs in the body play the same roles respectively, and can fundamentally solve the problem only after the normal operation.
Disclosure of Invention
The invention aims to solve the existing problems and provides a traditional Chinese medicine composition for treating diabetes and complications thereof. The scheme of the invention is as follows:
a traditional Chinese medicine composition for treating diabetes and complications thereof comprises the following components in parts by weight:
100-200 parts of emblic leafflower fruit, 80-120 parts of turmeric and 80-120 parts of barberry bark.
The improved food comprises the following components in parts by weight:
150 parts of emblic leafflower fruit, 100 parts of turmeric and 100 parts of barberry bark.
The invention has the advantages that:
1. the invention can comprehensively regulate the functions of organs such as stomach, liver, kidney, bladder and the like, and fundamentally treat diabetes.
2. The traditional Chinese medicine composition can effectively treat diabetes and complications thereof, has the effect of diuresis, and has obvious curative effects on complications such as renal hypofunction, edema of lower limbs, diabetic foot and the like caused by diabetes.
Detailed Description
The present invention will be described in detail and specifically with reference to the following examples so as to facilitate the understanding of the present invention, but the following examples do not limit the scope of the present invention.
Example 1
The embodiment discloses a traditional Chinese medicine composition for treating diabetes and complications thereof, which comprises the following components:
150g of emblic leafflower fruit, 100g of turmeric and 100g of barberry bark.
In the embodiment, the medicine is prepared into pills, and each pill is 0.2g and is taken with warm water after meal.
Example 2
The embodiment discloses a traditional Chinese medicine composition for treating diabetes and complications thereof, which comprises the following components:
100g of emblic leafflower fruit, 80g of turmeric and 80g of barberry bark.
In the embodiment, the medicine is prepared into pills, and each pill is 0.2g and is taken with warm water after meal.
Example 3
The embodiment discloses a traditional Chinese medicine composition for treating diabetes and complications thereof, which comprises the following components:
100g of emblic leafflower fruit, 80g of turmeric and 80g of barberry bark.
The above medicines are made into pills, each pill is 0.2g, and the pills are taken together with warm water after meal.
1-4 months in 2021, treating 40 patients with diabetes and secondary kidney diseases in autonomous state of Tibetan of Gansu, wherein the treatment time is 3 months, and the patients are retested once every month, and monitoring the victory index of the patients; wherein:
the symptoms of 16 patients are improved to a certain degree, the blood sugar is reduced, the renal function index is improved, and the edema of lower limbs is relieved; the symptoms of 21 patients are obviously improved, the indexes of blood sugar and renal function are kept normal, and edema of lower limbs is relieved; 3 patients were not effective after treatment.
The treatment result shows that the effective rate of the invention to diabetes and diabetic nephropathy is 92.5%, and the invention has good treatment effect.
The embodiments of the present invention have been described in detail above, but they are merely exemplary, and the present invention is not equivalent to the above described embodiments. Any equivalent modifications and substitutions to those skilled in the art are also within the scope of the present invention. Accordingly, it is intended that all equivalent alterations and modifications be included within the scope of the invention, without departing from the spirit and scope of the invention.
Claims (2)
1. A traditional Chinese medicine composition for treating diabetes and complications thereof is characterized by comprising the following components in parts by weight:
100-200 parts of emblic leafflower fruit, 80-120 parts of turmeric and 80-120 parts of barberry bark.
2. The traditional Chinese medicine composition for treating diabetes and complications thereof according to claim 1, which is characterized by comprising the following components in parts by weight:
150 parts of emblic leafflower fruit, 100 parts of turmeric and 100 parts of barberry bark.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210125300.7A CN114404550A (en) | 2022-02-10 | 2022-02-10 | A Chinese medicinal composition for treating diabetes and its complications |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210125300.7A CN114404550A (en) | 2022-02-10 | 2022-02-10 | A Chinese medicinal composition for treating diabetes and its complications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114404550A true CN114404550A (en) | 2022-04-29 |
Family
ID=81279827
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210125300.7A Withdrawn CN114404550A (en) | 2022-02-10 | 2022-02-10 | A Chinese medicinal composition for treating diabetes and its complications |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114404550A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102366595A (en) * | 2011-09-28 | 2012-03-07 | 久美彭措 | Medicine for treating diabetes and preparation method thereof |
| CN111388628A (en) * | 2020-04-15 | 2020-07-10 | 次仁 | Application of Tibetan medicine composition in preparing medicine for preventing and treating hyperlipidemia and diabetes |
-
2022
- 2022-02-10 CN CN202210125300.7A patent/CN114404550A/en not_active Withdrawn
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102366595A (en) * | 2011-09-28 | 2012-03-07 | 久美彭措 | Medicine for treating diabetes and preparation method thereof |
| CN111388628A (en) * | 2020-04-15 | 2020-07-10 | 次仁 | Application of Tibetan medicine composition in preparing medicine for preventing and treating hyperlipidemia and diabetes |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101744170B (en) | Tartary buckwheat eight ingredient porridge suitable for patients with diabetes and preparing method thereof | |
| CN104856003A (en) | Non-full nutritional formula food for patients with diabetes | |
| CN102783636A (en) | Food nutrition supplement for prophylaxis and treatment of diabetes and application thereof | |
| CN1802934A (en) | Dietetic bread cake for dietary cure for diabetes | |
| CN108295211A (en) | A kind of integration of drinking and medicinal herbs food prescription and preparation method thereof for treating diabetes | |
| CN107752024A (en) | A kind of nutritional meal replacing food for improving the metabolic disturbance diseases such as three height and obesity | |
| CN103445170A (en) | Spleen-tonifying and stomach-nourishing powder | |
| CN110384777A (en) | A kind of formula food of diabetesization sugar | |
| CN101890060B (en) | Preparation for nourishing pancreas islet, reducing blood sugar and regulating blood pressure and blood fat and preparation method thereof | |
| CN113712199A (en) | Weight-losing leaf-eating grass meal-replacing food | |
| CN110839805A (en) | Plant solid beverage | |
| CN107580496A (en) | The anti-glycosuria effect of gypenoside 75 | |
| CN103463407B (en) | Reason machine Jiangtang capsule | |
| CN101147584B (en) | Health-care food capable of preventing and treating diabetes and preparation method thereof | |
| CN114404550A (en) | A Chinese medicinal composition for treating diabetes and its complications | |
| CN102406711A (en) | Medicament for treating diabetes | |
| CN102150716B (en) | Medicinal tea with function of treating diabetes and preparation method thereof | |
| CN107998271A (en) | A kind of systematicness reduces Chinese medicine and health products that blood glucose repairs damaged cell | |
| CN107582845A (en) | A kind of Plant Powder for preventing and treating diabetes | |
| CN105663772B (en) | A kind of drug for treating diabetes | |
| CN115120684A (en) | Traditional Chinese medicine formula for treating diabetes and processing method thereof | |
| CN101745045A (en) | Food having therapeutic action to diseases of prostate gland and containing Chinese herbal medicines | |
| CN105031248A (en) | Health care product which contains Se-enriched cordyceps and is capable of assisting in blood sugar level regulation | |
| CN1970058A (en) | Chinese medicinal formulation for treating diabetes | |
| CN104621574A (en) | Formula food suitable for diabetic patients and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20220429 |
|
| WW01 | Invention patent application withdrawn after publication |